ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 424 out of 1383

$530K Total Retail Price of All Prescriptions

Rank: 317 out of 1383

424 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 4,877 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 324 146 1 5
LISINOPRIL 299 160 2 3
SIMVASTATIN 265 186 3 2
FUROSEMIDE 196 129 4 7
CARVEDILOL 194 96 5 24
LOVASTATIN 191 96 6 22
METFORMIN HCL 180 82 7 8
HYDROCODONE-ACETAMINOPHEN 178 80 S3 8 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 75 9 27
POTASSIUM CHLORIDE 149 81 10 12
HYDROCHLOROTHIAZIDE 146 106 11 10
GABAPENTIN 141 52 12 11
AMLODIPINE BESYLATE 135 93 13 6
ZOLPIDEM TARTRATE 133 52 14 17
LEVOTHYROXINE SODIUM 131 66 15 4
MELOXICAM 113 59 16 20
SYMBICORT 101 52 17 166
SINGULAIR 101 36 17 82
TAMSULOSIN HCL 95 70 19 30
TRAMADOL HCL 93 48 20 25
FLUTICASONE PROPIONATE 86 32 21 39
CRESTOR 81 25 22 34
METOPROLOL TARTRATE 77 55 23 9
ALENDRONATE SODIUM 77 71 23 37
CELEBREX 73 53 25 131
DONEPEZIL HCL 73 71 25 35
CLOPIDOGREL 70 57 27 28
PANTOPRAZOLE SODIUM 69 35 28 32
SPIRIVA 68 35 29 45
FENOFIBRATE 67 47 30 65
ATORVASTATIN CALCIUM 66 37 31 18
CITALOPRAM HBR 65 35 32 15
JANUVIA 65 22 32 85
PROAIR HFA 62 33 34 42
NAMENDA 61 59 35 49
SYNTHROID 60 36 36 73
METOPROLOL SUCCINATE 60 37 36 29
ESCITALOPRAM OXALATE 59 45 38 99
AZITHROMYCIN 59 33 38 41
DILTIAZEM HCL 58 30 40 203
CYMBALTA 57 35 41 53
PRAVASTATIN SODIUM 57 37 41 14
DICLOFENAC SODIUM 56 19 43 114
NITROFURANTOIN MONO-MACRO 55 37 44 193
NIASPAN 54 30 45 148
DEXILANT 53 14 46 140
TIZANIDINE HCL 52 0 47 104
LANSOPRAZOLE 51 16 48 169
ATENOLOL 50 36 49 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.